MAREX GROUP PLC (MRX) Fundamental Analysis & Valuation

NASDAQ:MRX • GB00BMT7GT62

34.88 USD
-0.91 (-2.54%)
At close: Mar 12, 2026
35 USD
+0.12 (+0.34%)
After Hours: 3/12/2026, 4:50:00 PM

This MRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

MRX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 242 industry peers in the Capital Markets industry. MRX may be in some trouble as it scores bad on both profitability and health. MRX is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. MRX Profitability Analysis

1.1 Basic Checks

  • In the past year MRX was profitable.
  • MRX had positive earnings in each of the past 5 years.
  • Of the past 5 years MRX 4 years had a positive operating cash flow.
MRX Yearly Net Income VS EBIT VS OCF VS FCFMRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • MRX's Return On Assets of 0.85% is on the low side compared to the rest of the industry. MRX is outperformed by 66.53% of its industry peers.
  • The Return On Equity of MRX (23.34%) is better than 89.67% of its industry peers.
Industry RankSector Rank
ROA 0.85%
ROE 23.34%
ROIC N/A
ROA(3y)0.81%
ROA(5y)0.81%
ROE(3y)20.25%
ROE(5y)17.22%
ROIC(3y)N/A
ROIC(5y)N/A
MRX Yearly ROA, ROE, ROICMRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • MRX has a Profit Margin (11.76%) which is in line with its industry peers.
  • MRX's Profit Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 44.29%, MRX is in line with its industry, outperforming 49.17% of the companies in the same industry.
  • MRX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 11.76%
GM 44.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.08%
PM growth 5YN/A
GM growth 3Y-5.15%
GM growth 5YN/A
MRX Yearly Profit, Operating, Gross MarginsMRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20 40

2

2. MRX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MRX has about the same amount of shares outstanding.
  • Compared to 1 year ago, MRX has an improved debt to assets ratio.
MRX Yearly Shares OutstandingMRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
MRX Yearly Total Debt VS Total AssetsMRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.23, we must say that MRX is in the distress zone and has some risk of bankruptcy.
  • MRX has a worse Altman-Z score (0.23) than 69.42% of its industry peers.
  • A Debt/Equity ratio of 11.45 is on the high side and indicates that MRX has dependencies on debt financing.
  • The Debt to Equity ratio of MRX (11.45) is worse than 89.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.45
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACCN/A
WACCN/A
MRX Yearly LT Debt VS Equity VS FCFMRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • MRX has a Current Ratio of 1.09. This is a normal value and indicates that MRX is financially healthy and should not expect problems in meeting its short term obligations.
  • MRX has a Current ratio (1.09) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.07 indicates that MRX should not have too much problems paying its short term obligations.
  • The Quick ratio of MRX (1.07) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.07
MRX Yearly Current Assets VS Current LiabilitesMRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 10B 20B 30B

8

3. MRX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 51.02% over the past year.
  • MRX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 46.97% yearly.
  • MRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.58%.
  • MRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.44% yearly.
EPS 1Y (TTM)51.02%
EPS 3Y46.97%
EPS 5YN/A
EPS Q2Q%48.68%
Revenue 1Y (TTM)27.58%
Revenue growth 3Y40.44%
Revenue growth 5YN/A
Sales Q2Q%37.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.56% on average over the next years. This is quite good.
  • Based on estimates for the next years, MRX will show a quite strong growth in Revenue. The Revenue will grow by 10.20% on average per year.
EPS Next Y6.77%
EPS Next 2Y9.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.11%
Revenue Next 2Y10.2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MRX Yearly Revenue VS EstimatesMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
MRX Yearly EPS VS EstimatesMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

4

4. MRX Valuation Analysis

4.1 Price/Earnings Ratio

  • MRX is valuated reasonably with a Price/Earnings ratio of 8.68.
  • Based on the Price/Earnings ratio, MRX is valued a bit cheaper than the industry average as 70.66% of the companies are valued more expensively.
  • MRX is valuated cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 8.13, which indicates a very decent valuation of MRX.
  • Based on the Price/Forward Earnings ratio, MRX is valued a bit cheaper than the industry average as 78.51% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of MRX to the average of the S&P500 Index (24.27), we can say MRX is valued rather cheaply.
Industry RankSector Rank
PE 8.68
Fwd PE 8.13
MRX Price Earnings VS Forward Price EarningsMRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRX Per share dataMRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y9.56%
EPS Next 3YN/A

2

5. MRX Dividend Analysis

5.1 Amount

  • MRX has a Yearly Dividend Yield of 1.67%.
  • MRX's Dividend Yield is slightly below the industry average, which is at 6.63.
  • MRX's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
MRX Yearly Dividends per shareMRX Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

DP0%
EPS Next 2Y9.56%
EPS Next 3YN/A
MRX Yearly Income VS Free CF VS DividendMRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

MRX Fundamentals: All Metrics, Ratios and Statistics

MAREX GROUP PLC

NASDAQ:MRX (3/12/2026, 4:50:00 PM)

After market: 35 +0.12 (+0.34%)

34.88

-0.91 (-2.54%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-03
Earnings (Next)05-13
Inst Owners74.17%
Inst Owner Change0%
Ins Owners6.43%
Ins Owner ChangeN/A
Market Cap2.54B
Revenue(TTM)2.51B
Net Income(TTM)295.00M
Analysts80
Price Target52.31 (49.97%)
Short Float %4.49%
Short Ratio4.39
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-16
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.03%
Min EPS beat(2)2.66%
Max EPS beat(2)9.4%
EPS beat(4)3
Avg EPS beat(4)5.43%
Min EPS beat(4)-0.13%
Max EPS beat(4)9.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.94%
Min Revenue beat(2)0.61%
Max Revenue beat(2)11.26%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)0.61%
Max Revenue beat(4)11.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.99%
PT rev (3m)6.85%
EPS NQ rev (1m)-0.84%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.16%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 8.68
Fwd PE 8.13
P/S 1.01
P/FCF N/A
P/OCF N/A
P/B 2.01
P/tB 2.74
EV/EBITDA N/A
EPS(TTM)4.02
EY11.53%
EPS(NY)4.29
Fwd EY12.31%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS34.42
BVpS17.34
TBVpS12.74
PEG (NY)1.28
PEG (5Y)N/A
Graham Number39.6
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 23.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 11.76%
GM 44.29%
FCFM N/A
ROA(3y)0.81%
ROA(5y)0.81%
ROE(3y)20.25%
ROE(5y)17.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.08%
PM growth 5YN/A
GM growth 3Y-5.15%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 11.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.07
Altman-Z 0.23
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.02%
EPS 3Y46.97%
EPS 5YN/A
EPS Q2Q%48.68%
EPS Next Y6.77%
EPS Next 2Y9.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.58%
Revenue growth 3Y40.44%
Revenue growth 5YN/A
Sales Q2Q%37.66%
Revenue Next Year11.11%
Revenue Next 2Y10.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MAREX GROUP PLC / MRX FAQ

What is the fundamental rating for MRX stock?

ChartMill assigns a fundamental rating of 4 / 10 to MRX.


What is the valuation status for MRX stock?

ChartMill assigns a valuation rating of 4 / 10 to MAREX GROUP PLC (MRX). This can be considered as Fairly Valued.


Can you provide the profitability details for MAREX GROUP PLC?

MAREX GROUP PLC (MRX) has a profitability rating of 3 / 10.


What is the earnings growth outlook for MAREX GROUP PLC?

The Earnings per Share (EPS) of MAREX GROUP PLC (MRX) is expected to grow by 6.77% in the next year.


Can you provide the dividend sustainability for MRX stock?

The dividend rating of MAREX GROUP PLC (MRX) is 2 / 10 and the dividend payout ratio is 0%.